{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T05:02:01Z","timestamp":1784869321681,"version":"3.55.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,2,23]],"date-time":"2018-02-23T00:00:00Z","timestamp":1519344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,2,23]],"date-time":"2018-02-23T00:00:00Z","timestamp":1519344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A serologic test for antibodies to chlamydial antigen pgp3 may be a useful tool for trachoma surveillance. However, little is known about the stability of antibody status over time, or factors associated with seroreversion\/conversion. A cohort of 2,111 children ages 1\u20139 years in Tanzania were followed for one year in the absence of mass azithromycin. At baseline and follow-up, they were evaluated for trachoma, chlamydial infection, and antibodies to chlamydial antigen pgp3. At baseline, 31% of children were seropositive for pgp3 antibodies and 6.4% seroreverted to negative over one year. Of those seronegative, 9.8% seroconverted over the year. The seroreverters had lower baseline mean fluorescence intensity (MFI-BG) values compared to the seropositives who remained positive (Odds Ratio\u2009=\u20090.04 for every unit increase in log<jats:sub>10<\/jats:sub>MFI-BG, 95% CI\u2009=\u20090.02\u20130.09), and were more likely to live in communities with trachoma &lt;5% (p\u2009&lt;\u20090.008). While seroconversion was expected, seroreversion was unexpected. The low seroprevalence rate reported from low endemic areas may be due to seroreversion as well as lack of exposure.<\/jats:p>","DOI":"10.1038\/s41598-018-21127-0","type":"journal-article","created":{"date-parts":[[2018,2,19]],"date-time":"2018-02-19T10:15:58Z","timestamp":1519035358000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Longitudinal change in the serology of antibodies to Chlamydia trachomatis pgp3 in children residing in a trachoma area"],"prefix":"10.1038","volume":"8","author":[{"given":"Sheila K.","family":"West","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Munoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemjot","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Dize","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harran","family":"Mkocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte A.","family":"Gaydos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,23]]},"reference":[{"key":"21127_CR1","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1016\/S0140-6736(13)62182-0","volume":"384","author":"HR Taylor","year":"2014","unstructured":"Taylor, H. R., Burton, M. J., Haddad, D., West, S. & Wright, H. Trachoma. Lancet 384, 2142\u20132152, https:\/\/doi.org\/10.1016\/S0140-6736(13)62182-0 (2014).","journal-title":"Lancet"},{"key":"21127_CR2","unstructured":"World_Health_Organization. in WHA51.11 (ed World_Health_Assembly) (1998)."},{"key":"21127_CR3","unstructured":"World_Health_Organization. Technical Consultation on Trachoma Surveillance. 1\u201323 (World Health Organization Press Geneva, Switzerland, 2015)."},{"key":"21127_CR4","doi-asserted-by":"publisher","first-page":"e0003555","DOI":"10.1371\/journal.pntd.0003555","volume":"9","author":"DL Martin","year":"2015","unstructured":"Martin, D. L. et al. Serology for trachoma surveillance after cessation of mass drug administration. PLoS Negl Trop Dis 9, e0003555, https:\/\/doi.org\/10.1371\/journal.pntd.0003555 (2015).","journal-title":"PLoS Negl Trop Dis"},{"key":"21127_CR5","doi-asserted-by":"publisher","first-page":"e2115","DOI":"10.1371\/journal.pntd.0002115","volume":"7","author":"EM Harding-Esch","year":"2013","unstructured":"Harding-Esch, E. M. et al. Mass treatment with azithromycin for trachoma: when is one round enough? Results from the PRET Trial in the Gambia. PLoS Negl Trop Dis 7, e2115, https:\/\/doi.org\/10.1371\/journal.pntd.0002115 (2013).","journal-title":"PLoS Negl Trop Dis"},{"key":"21127_CR6","doi-asserted-by":"publisher","first-page":"e0004352","DOI":"10.1371\/journal.pntd.0004352","volume":"10","author":"SK West","year":"2016","unstructured":"West, S. K. et al. Can We Use Antibodies to Chlamydia trachomatis as a Surveillance Tool for National Trachoma Control Programs? Results from a District Survey. PLoS Negl Trop Dis 10, e0004352, https:\/\/doi.org\/10.1371\/journal.pntd.0004352 (2016).","journal-title":"PLoS Negl Trop Dis"},{"key":"21127_CR7","doi-asserted-by":"publisher","first-page":"e376","DOI":"10.1371\/journal.pntd.0000376","volume":"3","author":"T Lakew","year":"2009","unstructured":"Lakew, T. et al. Reduction and return of infectious trachoma in severely affected communities in ethiopia. PLoS. Negl. Trop. Dis. 3, e376 (2009).","journal-title":"PLoS. Negl. Trop. Dis."},{"key":"21127_CR8","doi-asserted-by":"publisher","first-page":"e1873","DOI":"10.1371\/journal.pntd.0001873","volume":"6","author":"EB Goodhew","year":"2012","unstructured":"Goodhew, E. B. et al. CT694 and pgp3 as serological tools for monitoring trachoma programs. PLoS Negl Trop Dis 6, e1873, https:\/\/doi.org\/10.1371\/journal.pntd.0001873 (2012).","journal-title":"PLoS Negl Trop Dis"},{"key":"21127_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-216","volume":"14","author":"EB Goodhew","year":"2014","unstructured":"Goodhew, E. B. et al. Longitudinal analysis of antibody responses to trachoma antigens before and after mass drug administration. BMC infectious diseases 14, 216, https:\/\/doi.org\/10.1186\/1471-2334-14-216 (2014).","journal-title":"BMC infectious diseases"},{"key":"21127_CR10","doi-asserted-by":"publisher","first-page":"e0005003","DOI":"10.1371\/journal.pntd.0005003","volume":"10","author":"AI Zambrano","year":"2016","unstructured":"Zambrano, A. I. et al. TheWorld Health Organization Recommendations for Trachoma Surveillance, Experience in Nepal and Added Benefit of Testing for Antibodies to Chlamydia trachomatis pgp3 Protein: NESTS Study. PLoS Negl Trop Dis 10, e0005003, https:\/\/doi.org\/10.1371\/journal.pntd.0005003 (2016).","journal-title":"PLoS Negl Trop Dis"},{"key":"21127_CR11","doi-asserted-by":"publisher","first-page":"e0004462","DOI":"10.1371\/journal.pntd.0004462","volume":"10","author":"BP Pant","year":"2016","unstructured":"Pant, B. P. et al. Control of Trachoma from Achham District, Nepal: A Cross-Sectional Study from the Nepal National Trachoma Program. PLoS Negl Trop Dis 10, e0004462, https:\/\/doi.org\/10.1371\/journal.pntd.0004462 (2016).","journal-title":"PLoS Negl Trop Dis"},{"key":"21127_CR12","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1080\/09286586.2016.1238947","volume":"23","author":"AM Ervin","year":"2016","unstructured":"Ervin, A. M. et al. Surveillance and Azithromycin Treatment for Newcomers and Travelers Evaluation (ASANTE) Trial: Design and Baseline Characteristics. Ophthalmic Epidemiol 23, 347\u2013353, https:\/\/doi.org\/10.1080\/09286586.2016.1238947 (2016).","journal-title":"Ophthalmic Epidemiol"},{"key":"21127_CR13","first-page":"477","volume":"65","author":"B Thylefors","year":"1987","unstructured":"Thylefors, B., Dawson, C., Jones, B. R., West, S. K. & Taylor, H. R. A simple system for the assessment of trachoma and its complications. Bull WHO 65, 477\u2013483 (1987).","journal-title":"Bull WHO"},{"key":"21127_CR14","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.diagmicrobio.2013.08.005","volume":"77","author":"L Dize","year":"2013","unstructured":"Dize, L., West, S., Quinn, T. C. & Gaydos, C. A. Pooling ocular swab specimens from Tanzania for testing by Roche Amplicor and Aptima Combo 2 assays for the detection of Chlamydia trachomatis: accuracy and cost-savings. Diagnostic microbiology and infectious disease 77, 289\u2013291, https:\/\/doi.org\/10.1016\/j.diagmicrobio.2013.08.005 (2013).","journal-title":"Diagnostic microbiology and infectious disease"},{"key":"21127_CR15","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.diagmicrobio.2014.11.010","volume":"81","author":"L Dize","year":"2015","unstructured":"Dize, L., West, S. K., Mkocha, H., Quinn, T. C. & Gaydos, C. A. Evaluation of pooled ocular and vaginal swabs by the Cepheid GeneXpert CT\/NG assay for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae compared to the GenProbe Aptima Combo 2 Assay. Diagnostic microbiology and infectious disease 81, 102\u2013104, https:\/\/doi.org\/10.1016\/j.diagmicrobio.2014.11.010 (2015).","journal-title":"Diagnostic microbiology and infectious disease"},{"key":"21127_CR16","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1021\/ci2003076","volume":"51","author":"A Perez-Garrido","year":"2011","unstructured":"Perez-Garrido, A. et al. Two New Parameters Based on Distances in a Receiver Operating Characteristic Chart for the Selection of Classification Models. J Chem Inf Model 51, 2746\u20132759, https:\/\/doi.org\/10.1021\/ci2003076 (2011).","journal-title":"J Chem Inf Model"},{"key":"21127_CR17","doi-asserted-by":"publisher","first-page":"e0005230","DOI":"10.1371\/journal.pntd.0005230","volume":"11","author":"SJ Migchelsen","year":"2017","unstructured":"Migchelsen, S. J. et al. Defining Seropositivity Thresholds for Use in Trachoma Elimination Studies. PLoS Negl Trop Dis 11, e0005230, https:\/\/doi.org\/10.1371\/journal.pntd.0005230 (2017).","journal-title":"PLoS Negl Trop Dis"},{"key":"21127_CR18","doi-asserted-by":"crossref","unstructured":"Leuridan, E., Hens, N., Hutse, V., Aerts, M. & Van Damme, P. Kinetics of maternal antibodies against rubella and varicella in infants. Vaccine 29, 2222\u20132226 (2011).","DOI":"10.1016\/j.vaccine.2010.06.004"},{"key":"21127_CR19","doi-asserted-by":"crossref","unstructured":"Watanaveeradej V. et al. Transplacentally transferred maternal-infant antibodies to dengue virus. Am J Trop Med Hyg 69, 123\u2013128 (2003).","DOI":"10.4269\/ajtmh.2003.69.123"},{"key":"21127_CR20","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1136\/sextrans-2011-050386","volume":"89","author":"PJ Horner","year":"2013","unstructured":"Horner, P. J. et al. Effect of time since exposure to Chlamydia trachomatis on chlamydia antibody detection in women: a cross-sectional study. Sexually transmitted infections 89, 398\u2013403, https:\/\/doi.org\/10.1136\/sextrans-2011-050386 (2013).","journal-title":"Sexually transmitted infections"},{"key":"21127_CR21","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1128\/CVI.00021-09","volume":"16","author":"GS Wills","year":"2009","unstructured":"Wills, G. S. et al. Pgp3 antibody enzyme-linked immunosorbent assay, a sensitive and specific assay for seroepidemiological analysis of Chlamydia trachomatis infection. Clinical and vaccine immunology: CVI 16, 835\u2013843, https:\/\/doi.org\/10.1128\/CVI.00021-09 (2009).","journal-title":"Clinical and vaccine immunology: CVI"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-21127-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-21127-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-21127-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T02:50:28Z","timestamp":1671591028000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-21127-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,23]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["21127"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-21127-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,23]]},"assertion":[{"value":"14 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"3520"}}